Floatz logo

Verdiperstat

Semantic Dementia

Peter Ljubenkov, MDSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Semantic Dementia cohort.

Asset / SponsorPhaseRating
Namenda
University of California, San Francisco
Phase 4BB
FLUDEOXYGLUCOSE
Mayo Clinic
Phase 1CC
PITTSBURGH COMPOUND B UNLABELLED
Mayo Clinic
Phase 1CC
FLORTAUCIPIR
Mayo Clinic
D
ER-176
Mayo Clinic
D

Same molecule, other indications

Verdiperstat is also rated in:

Parkinson diseaseDormant
B
Indicative ·
61 / 100
View asset →
amyotrophic lateral sclerosisDormant
CCC
Indicative ·
55 / 100
View asset →
multiple system atrophyDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →